- Visibility 32 Views
- Downloads 16 Downloads
- Permissions
- DOI 10.18231/j.ijcbr.12165.1852744896
-
CrossMark
Aggravated dyslipidemia in comorbid T2DM and hypothyroidism: A Comparative analysis among the peoples of north Bihar
- Author Details:
-
Zeenat Inam *
Zeenat Inam *
Background: Type 2 diabetes mellitus (T2DM) and hypothyroidism are prevalent endocrine disorders, each associated with significant metabolic disturbances. Their coexistence may exacerbate glycemic and lipid abnormalities, increasing cardiovascular risk. This study aimed to evaluate and compare glycemic status, thyroid function, and lipid profiles among individuals with T2DM, hypothyroidism, both conditions, and healthy controls
Materials and Methods: A cross-sectional study was conducted including 360 participants divided equally into four groups: Group A (T2DM only), Group B (hypothyroidism only), Group C (T2DM + hypothyroidism), and Group D (healthy controls). Fasting plasma glucose, postprandial glucose, HbA1c, thyroid-stimulating hormone (TSH), free T3, free T4, and comprehensive lipid profiles were measured. Statistical analysis was performed using independent t-tests, with significance set at p < 0.05
Results: Group C exhibited significantly higher fasting plasma glucose (178.9 ± 33.4 mg/dL), postprandial glucose (258.5 ± 40.3 mg/dL), and HbA1c (8.9 ± 1.3%) compared to Group A (p < 0.01). TSH levels were markedly elevated in Group C (10.6 ± 5.2 µIU/mL) versus Group A (3.1 ± 1.2 µIU/mL; p < 0.0001), with significantly lower free T3 and free T4. Group C also demonstrated the most severe dyslipidemia, with higher total cholesterol (226.9 ± 38.2 mg/dL), LDL-C (148.6 ± 28.1 mg/dL), triglycerides (220.3 ± 52.7 mg/dL), and VLDL-C (44.1 ± 10.5 mg/dL), and lower HDL-C (35.6 ± 6.0 mg/dL) compared to all other groups (all p < 0.01).
Conclusion: The coexistence of T2DM and hypothyroidism results in significantly worse glycemic control, thyroid dysfunction, and lipid abnormalities than either condition alone. Routine thyroid screening in T2DM patients is warranted to identify and manage hypothyroidism early, thereby mitigating compounded metabolic and cardiovascular risk.
References
- Chaker L, Bianco AC, Jonklaas J, Peeters RP. Hypothyroidism. Lancet Diab Endocrinol. 2017;5(11):933–44.
- Brenta G, Vaisman M, Chidakel A, Farwell AP, Klein I. Management of hypothyroidism in adults: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2020;105(12): e4260–72.
- Lee YK, Kim JE, Oh HJ, Park KS, Park YJ. Association between thyroid dysfunction and insulin resistance in Korean population. J Clin Med. 2021;10(4):809. DOI:10.1038/s41598-021-01101-z
[Google Scholar] - International Diabetes Federation. IDF Diabetes Atlas. 10th ed. Brussels: Int Diab Federation; 2021.
- Chaker L, Bianco AC, Jonklaas J, Peeters RP. Hypothyroidism. Lancet. 2017;390(10101):1550–62. DOI: 10.1016/S0140-6736(17)30703-1
[Google Scholar] - Duntas LH, Orgiazzi J, Brabant G. The interface between thyroid and diabetes mellitus. Clin Endocrinol (Oxf). 2011;75(1):1–9. DOI: 10.1111/j.1365-2265.2011.04029.x
[Google Scholar] - Taskinen MR, Packard CJ, Boren J. Emerging evidence that ApoC-III inhibitors provide novel options to reduce the residual CVD. Curr Atheroscler Rep. 2019;21(8):27. DOI: 10.1007/s11883-019-0791-9
[Google Scholar] - Pearce EN. Hypothyroidism and dyslipidemia: modern concepts and approaches. Curr Cardiovasc Risk Rep. 2004;12(5):473–9. DOI: 10.1007/s11886-004-0054-3
[Google Scholar] - Lewis GF, Carpentier A, Adeli K, Giacca A. Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes. Endocr Rev. 2002;23(2):201–29. DOI: 10.1210/edrv.23.2.0461
[Google Scholar] - Younis N, Sharma R, Soran H, Charlton-Menys V, Elseweidy M, Durrington PN. Glycation as an atherogenic modification of LDL. Curr Opin Lipidol . 2008;19(4):378 –84. DOI: 10.1097/MOL.0b013e328306a057
[Google Scholar] - Pearce EN. Update in lipid alterations in subclinical hypothyroidism. Nat Rev Endocrinol. 2012;97(2):326–33. DOI: 10.1210/jc.2011-2532
[Google Scholar] - Anpalahan M, Gibson S. Subclinical hypothyroidism and diabetes risk: a case-control study. Diab Metab Syndr. 2021;15(4):102193.
- Jain G, et al. Lipid abnormalities in hypothyroid patients: a study from North India. Indian J Endocrinol Metab. 2020;24(3):247–52.
- Duntas LH. Thyroid disease and lipids. Thyroid. 2002;12(4):287–93.
- Biondi B, Klein I. Hypothyroidism as a risk factor for cardiovascular disease. Endocrine. 2004;24(1):1–13. DOI: 10.1385/ENDO:24:1:001
[Google Scholar] - Brenta G, Danzi S, Klein I. Potential therapeutic applications of thyroid hormone analogs. Nat Clin Pract Endocrinol Metab. 2007;3(9):632–
- DOI: 10.1038/ncpendmet0590
[Google Scholar] - Danese MD, Ladenson PW, Meinert CL, Powe NR. Effect of thyroxine therapy on serum lipoproteins in patients with mild thyroid failure: a quantitative review of the literature. J Clin Endocrinol Metab. 2000;85(9):2993–3001. DOI: 10.1210/jcem.85.9.6841
[Google Scholar] - Trinder P. Determination of blood glucose using an oxidase-peroxidase system with a non-carcinogenic chromogen. J Clin Pathol. 1969;22(2):158–6. DOI: 10.1136/jcp.22.2.158
[Google Scholar] - Bhagat CI, Garcia-Webb P, Watson F, Beilby JP. Interference in radioimmunoassay of total serum thyroxine due to thyroxine binding autoantibodies. Clin Chem. 1983; 29:1324–5.
- Alani CC, Poon LS, Chan CS, Richmond W, Fu PC. Enzymatic determination of total serum cholesterol. Clin Chem. 1974;20(4):470–
- Bucolo G, David H. Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem. 1973;19(5):476–82.
- Lee Y, Kim H, Lee WH, Lee DH, Lee YJ, Kim JY, et al. Reference intervals for total T4 and free T4 in cynomolgus monkeys (Macacafascicularis). J Am Assoc Lab Anim Sci. 2021;60(5):517–22. doi: 10.30802/AALAS-JAALAS-20-000126
[Google Scholar] - Kaur R, Mukundan S. Metabolic comorbidities in diabetes and hypothyroidism. J Endocrinol. 2023;45(3):123–30. doi:10.1210/er.2018-00163
[Google Scholar] - Sharma A, et al. Thyroid dysfunction and lipid profiles in T Diabetes Res. 2024;12(2):89–95. doi:10.1210/er.2018-00163
[Google Scholar]